Pulik Richard
Reporting owner on Forms 3, 4 and 5, CIK 1885841.
Pulik Richard reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-12.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ROIV · Roivant Sciences Ltd.CIK 1635088 | officer (CFO) | 1 | 2026-11-12 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ROIV · Roivant Sciences Ltd.Common Shares | 2026-11-11 | M exercised | +127,365 | $3.85 | 397,046 | Form 4 |
| ROIV · Roivant Sciences Ltd.Common Shares | 2026-11-11 | S sold | -45,195 | $41.47 | 351,851 | Form 4 |
| ROIV · Roivant Sciences Ltd.Common Shares | 2026-11-11 | S sold | -82,170 | $42.03 | 269,681 | Form 4 |
| ROIV · Roivant Sciences Ltd.Common Shares | 2026-11-11 | S sold | -47,635 | $41.89 | 222,046 | Form 4 |
| ROIV · Roivant Sciences Ltd.Stock Option (Right to Buy), derivative | 2026-11-11 | M exercised | -127,365 | $0 | 487,635 | Form 4 |
| ROIV · Roivant Sciences Ltd.Common Shares | 2026-11-10 | M exercised | +125,000 | $3.85 | 394,681 | Form 4 |
| ROIV · Roivant Sciences Ltd.Common Shares | 2026-11-10 | S sold | -125,000 | $41.2 | 269,681 | Form 4 |
| ROIV · Roivant Sciences Ltd.Stock Option (Right to Buy), derivative | 2026-11-10 | M exercised | -125,000 | $0 | 615,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001635088-26-000139 | Roivant Sciences Ltd. | 2026-11-12 |